Functional brain region-specific neural spheroids for modeling neurological diseases and therapeutics screening.
Caroline E StrongJiajing ZhangMartin CarrascoSrikanya KunduMolly BoutinHarshad D VishwasraoJiamin LiuAngelica MedinaYu-Chi ChenKelli M WilsonEmily M LeeMarc FerrerPublished in: Communications biology (2023)
3D spheroids have emerged as powerful drug discovery tools given their high-throughput screening (HTS) compatibility. Here, we describe a method for generating functional neural spheroids by cell-aggregation of differentiated human induced pluripotent stem cell (hiPSC)-derived neurons and astrocytes at cell type compositions mimicking specific regions of the human brain. Recordings of intracellular calcium oscillations were used as functional assays, and the utility of this spheroids system was shown through disease modeling, drug testing, and formation of assembloids to model neurocircuitry. As a proof of concept, we generated spheroids incorporating neurons with Alzheimer's disease-associated alleles, as well as opioid use disorder modeling spheroids induced by chronic treatment of a mu-opioid receptor agonist. We reversed baseline functional deficits in each pilot disease model with clinically approved treatments and showed that assembloid activity can be chemogenetically manipulated. Here, we lay the groundwork for brain region-specific neural spheroids as a robust functional assay platform for HTS studies.
Keyphrases
- stem cells
- drug discovery
- high throughput
- spinal cord
- endothelial cells
- traumatic brain injury
- clinical trial
- resting state
- chronic pain
- single cell
- white matter
- emergency department
- randomized controlled trial
- small molecule
- pain management
- spinal cord injury
- high glucose
- oxidative stress
- drug induced
- cognitive decline
- pluripotent stem cells